Dactinomycin

CAS 50-76-0 2 current records 2 historicalSmall Molecule

Who holds supplier records for Dactinomycin? 2 organisations hold a current record for Dactinomycin: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (1) and China (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Dactinomycin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dactinomycin

Reading the evidence

  • 2 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (2)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Dactinomycin. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Dactinomycin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (2)

Organisations whose Type II DMFs for Dactinomycin are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • SIGMA CHEMICAL CO
    Inactive DMF 13633 · filed Sept 1998
  • SIGMA ALDRICH ISRAEL LTD
    Inactive DMF 3538 · filed Apr 1979

Overview

Dactinomycin is a chromopeptide antibiotic used in chemotherapy that inhibits RNA synthesis. It is mainly employed in the treatment of various types of cancer like Wilms’ tumor and rhabdomyosarcoma.

Chemical identity

IUPAC name
2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
Canonical SMILES
C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C
InChIKey
RJURFGZVJUQBHK-IIXSONLDSA-N
Synonyms
Actinomycin D, actinomycin c1, actinomycin i1, actinomycin iv, actinomycin x1, actinomycin-d, cosmegen, dactinomycinum, dilactone actinomycin d acid, gnf-pf-2290, meractinomycin, nci-c04682

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Actinomycin
Mechanism of action
Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors

Therapeutic areas

Oncology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Dactinomycin?

2 organisations hold an active US FDA Type II Drug Master File or a CEP for Dactinomycin: CONCORD BIOTECH LTD (India) and Zhejiang Hisun Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Dactinomycin Drug Master Files are active?

CONCORD BIOTECH LTD (DMF 34247) and Zhejiang Hisun Pharmaceutical Co., Ltd. (DMF 20658). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Dactinomycin records mean?

2 organisations have only inactive Type II DMFs for Dactinomycin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Dactinomycin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Dactinomycin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.